Tsuneyoshi Hiroshi, Rao Vivek
Division of Cardiovascular Surgery, Peter Munk Cardiac Centre, Toronto General Hospital, University of Toronto, Toronto, ON, Canada.
Int Anesthesiol Clin. 2012 Summer;50(3):114-22. doi: 10.1097/AIA.0b013e3182603ed5.
ECMO is a reliable and useful treatment for patient with acute cardiac failure. However, outcomes of cardiac ECMO are not yet as successful as case of ECMO support for respiratory failure. To improve the results of cardiac ECMO, proper patient selection, management, and weaning strategy are crucial. Other options, including LVADs and heart transplant, should be considered when patients do not show any improvements under ECMO therapy. A multidisciplinary approach is required to provide the maximum chance of survival after ECMO treatment.
体外膜肺氧合（ECMO）是治疗急性心力衰竭患者的一种可靠且有用的方法。然而，心脏ECMO的治疗效果尚未像ECMO支持呼吸衰竭那样成功。为了提高心脏ECMO的治疗效果，合适的患者选择、管理和撤机策略至关重要。当患者在ECMO治疗下没有任何改善时，应考虑其他选择，包括左心室辅助装置（LVADs）和心脏移植。需要采取多学科方法，以提供ECMO治疗后最大的生存机会。
